BWX Technologies, Inc. Reports Strong Q1 2026 Results, Raises Guidance and Announces Strategic Acquisition

Key Financial Highlights

• Q1 2026 Revenue: \$860.2 million, up 26% from \$682.3 million in Q1 2025
• Q1 2026 Net Income: \$91.2 million (GAAP), up 21% from \$75.5 million in Q1 2025
• Adjusted EBITDA: \$148.0 million, up 14% from \$129.8 million in Q1 2025
• EPS: GAAP \$0.99 (up 21%); Non-GAAP \$1.12 (up 22%)
• Free Cash Flow: \$50.1 million, up 190% from \$17.3 million in Q1 2025
• Raised 2026 Guidance:
  • Adjusted EBITDA: \$650-\$665 million (up from \$645-\$660 million)
  • Non-GAAP EPS: \$4.60-\$4.75 (up from \$4.55-\$4.70)
  • Free Cash Flow: \$315-\$330 million (up from \$305-\$320 million)
  • Revenue: >\$3,750 million (up from \$3,198 million in 2025)
• Backlog: \$8.65 billion (up from \$4.88 billion in Q1 2025)

Strategic Developments

• Acquisition of Precision Components Group, LLC (PCG): Announced as a strategic move to establish a U.S. footprint in commercial nuclear component manufacturing.
• Robust Performance Across Segments:
  • Government Operations revenue up 4% (\$577.9 million), driven by special materials processing and naval reactor growth (partially offset by lower microreactor volumes).
  • Commercial Operations revenue up 121% (\$283.6 million), driven by nuclear components, field services, fuel handling, medical sales, and contribution from Kinectrics.
• Dividend: \$0.27 per share for Q1 2026. Next dividend payable on June 5, 2026, to shareholders of record on May 19, 2026.

Operational and Financial Details

Segment Performance

• Government Operations: Operating income increased to \$99.1 million (up from \$97.7 million), with adjusted EBITDA at \$117.7 million. Growth was driven by special materials and naval reactors.
• Commercial Operations: Operating income surged to \$24.0 million (up from \$6.5 million), with adjusted EBITDA at \$36.5 million (up 162%). Growth due to higher commercial nuclear revenues and improved operational performance.
• Corporate Expenses: Higher restructuring, transformation, and acquisition-related costs led to increased corporate expenses.

Cash Flow & Capital Expenditures

• Operating cash flow: \$92.6 million (up from \$50.7 million in Q1 2025)
• Capital expenditures: \$42.5 million (up from \$33.4 million)
• Free cash flow: \$50.1 million (up from \$17.3 million)
• Dividends paid: \$25.8 million

Balance Sheet and Liquidity

• Total assets: \$4.32 billion (up from \$4.27 billion at year-end 2025)
• Cash and cash equivalents: \$512.4 million
• Total liabilities: \$3.04 billion
• Stockholders’ equity: \$1.28 billion

Forward-Looking Guidance and Risks

• BWXT raised its 2026 guidance for revenue, adjusted EBITDA, non-GAAP EPS, and free cash flow, reflecting strong Q1 performance and optimistic market outlook.
• Guidance excludes contributions from the PCG acquisition, presenting potential upside if the acquisition outperforms expectations.
• Risks:
  • Government budget uncertainty, possible future budget cuts, and funding mechanism risks.
  • Potential industry disruptions, labor market challenges, regulatory changes, and supply chain constraints.
  • Market demand shifts and competitiveness in nuclear products and services.
  • Risks associated with execution of contracts in backlog and timing of new technology deployment.

Investor Considerations

• Shareholder Value Drivers:
  • Significant backlog growth may signal strong future revenue streams.
  • Adjusted EBITDA and EPS guidance upgrades can positively impact share price.
  • Strategic acquisition of PCG positions BWXT for expansion in commercial nuclear markets, potentially enhancing long-term value.
  • Strong cash flow growth and robust dividend payments reinforce financial stability and shareholder returns.
• Price Sensitive Information:
  • Raised financial guidance and backlog increase are likely to be viewed positively by investors.
  • The PCG acquisition is a notable strategic development with potential for revenue and margin expansion.

Non-GAAP Measures and Reconciliations

• BWXT provides non-GAAP measures (adjusted EBITDA, non-GAAP EPS, free cash flow) to supplement GAAP results. These measures are intended to give investors greater insight into ongoing operational performance.
• Non-GAAP adjustments include restructuring, transformation, acquisition-related costs, and amortization.
• Definitions and detailed reconciliations are provided in the full earnings release and on BWXT’s investor relations website.

Conclusion

BWX Technologies delivered a robust first quarter, highlighted by substantial revenue growth, improved profitability, and strong cash flow. The company’s strategic acquisition and upward revision of guidance signal a positive outlook for 2026. Investors should monitor the integration of PCG, execution of backlog, and any developments regarding government funding and nuclear market demand.

Disclaimer: The above article is based on BWX Technologies, Inc.’s Q1 2026 financial report and related investor materials. This is not investment advice. Investors are encouraged to review the full earnings release and consult professional advisors before making investment decisions. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied.

View BWX Technologies, Inc. Historical chart here